An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships

被引：3
|
作者：
Wang, Jiangming [1 ]
Sun, Xiaojing [1 ]
Li, Na [1 ]
Sheng, Ruilong [2 ]
Guo, Ruihua [1 ,3 ,4 ]
机构：
[1] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai 201306, Peoples R China
[2] Univ Madeira, CQM Cent Quim Madeira, Campus Penteada, P-9000390 Funchal, Portugal
[3] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai 201306, Peoples R China
[4] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stora, Shanghai 201306, Peoples R China
来源：
CURRENT MEDICINAL CHEMISTRY | 2023年 / 30卷 / 25期
基金：
中国国家自然科学基金;
关键词：
Antithrombotic; thrombin inhibitor; structure-activity relationship; pharmacokinetics; PROTEASE-ACTIVATED RECEPTORS; DESIGNING ALLOSTERIC REGULATORS; OPTIMIZING PLATELET INHIBITION; ORALLY BIOAVAILABLE SERIES; FACTOR XA INHIBITORS; BIOLOGICAL EVALUATION; ANTITHROMBOTIC COMPOUNDS; IN-VITRO; PART; SCUTELLAREIN DERIVATIVES;
D O I：
10.2174/0929867329666220906105200
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thrombosis is one of the most important pathogenic factors related to cardiovascular diseases. Presently, thrombin inhibitors have gradually gained prominence in clinical practice due to their unique potential, such as dabigatran. Nevertheless, the risk of bleeding is not completely eliminated, and the threats of gastrointestinal bleeding are even increased in some cases. Therefore, developing new oral thrombin inhibitors with low side effects is urgent. In this paper, we summarized recent advances in the newly synthesized and isolated thrombin inhibitors from 2000 to 2019 and their structure-activity relationships (SARs) along with structure-dependent pharmacokinetic parameters, guiding the next generation of oral thrombin inhibitors.
引用
收藏
页码：2864 / 2930
页数：67
相关论文
共 50 条
  • [1] Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016)
    Carullo, G.
    Galligano, F.
    Aiello, F.
    MEDCHEMCOMM, 2017, 8 (03) : 492 - 500
  • [2] Overview of Piperine: Bioactivities, Total Synthesis, Structural Modification, and Structure-Activity Relationships
    Li, Shaochen
    Lv, Min
    Xu, Hui
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (08) : 917 - 940
  • [3] Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships
    Poli, Giulio
    Di Fabio, Romano
    Ferrante, Luca
    Summa, Vincenzo
    Botta, Maurizio
    CHEMMEDCHEM, 2017, 12 (23) : 1917 - 1926
  • [4] An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking
    Yang, Wei
    Feng, Qianqian
    Peng, Zhiyun
    Wang, Guangcheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 234
  • [5] Design, Synthesis, and Structure-Activity Relationships of Azolylmethylpyrroloquinolines as Nonsteroidal Aromatase Inhibitors
    Ferlin, Maria Grazia
    Carta, Davide
    Bortolozzi, Roberta
    Ghodsi, Razieh
    Chimento, Adele
    Pezzi, Vincenzo
    Moro, Stefano
    Hanke, Nina
    Hartmann, Rolf W.
    Basso, Giuseppe
    Viola, Giampietro
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7536 - 7551
  • [6] Structure-activity relationships of some complex I inhibitors
    Miyoshi, H
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02): : 236 - 244
  • [7] Dietary Flavonoids as Xanthine Oxidase Inhibitors: Structure-Affinity and Structure-Activity Relationships
    Lin, Suyun
    Zhang, Guowen
    Liao, Yijing
    Pan, Junhui
    Gong, Deming
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2015, 63 (35) : 7784 - 7794
  • [8] Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism
    Huang, Mengyuan
    Huang, Jiangkun
    Zheng, Yongcheng
    Sun, Qiu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 178 : 259 - 286
  • [9] Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors
    Ferraris, D. V.
    Shukla, K.
    Tsukamoto, T.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (09) : 1282 - 1294
  • [10] Oxazolones: New tyrosinase inhibitors; synthesis and their structure-activity relationships
    Khan, Khalid Mohammed
    Mughal, Uzma Rasool
    Khan, Mahmud Tareq Hassan
    Zia-Ullah
    Perveen, Shahnaz
    Choudhary, Muhammad Iqbal
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 6027 - 6033
12345